Scientific News Boston Scientific S Swot Analysis Medtech Giant S Stock Poised For Growth
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific S Swot Analysis Medtech Giant S Stock Poised For Growth is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Acquisitive Boston Scientific sees growth rate ease in Q3
Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year. Growth eased slightly from the second quarter, when sales rose more than 22%. Urology led the gains, up 28% year ... Read More
Analysts project durable growth with many near-term catalysts for Boston Scientific
Analysts remain high on Boston Scientific after a visit to the company's Marlborough, Massachusetts headquarters. Read More
Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost
Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?
Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus